Daytime Hypersomnolence in COVID-19: A Case Report and Literature Review
Acta Medica Iranica
; 59(12):740-742, 2021.
Article
in English
| EMBASE | ID: covidwho-1667850
ABSTRACT
Coronavirus infectious disease 2019 (COVID-19) is confirmed to develop neurocognitive complications. In the present paper, we describe two patients with laboratory-confirmed COVID-19 and excessive daytime sleepiness. In the present study, we reported two laboratory-confirmed cases of COVID-19 with excessive daytime sleepiness. Patients had drowsiness and mild confusion on presentation. In both cases, CNS infections, including meningitis and encephalitis, were ruled out. Both patients’ symptoms remarkably improved following the therapeutic course indicating the direct effect of SARS-CoV2 in sleep modulating centers on the brain. COVID-19 should be considered in patients with excessive daytime sleepiness and drowsiness in the current outbreak.
azithromycin; hydroxychloroquine; naproxen; adult; aged; article; case report; central nervous system; central nervous system infection; clinical article; confusion; coronavirus disease 2019; disorders of higher cerebral function; drowsiness; encephalitis; excessive daytime sleepiness; female; fever; human; male; middle aged; myalgia; neck pain; nonhuman; prevalence; real time polymerase chain reaction; Severe acute respiratory syndrome coronavirus 2; sleep; smelling disorder; somnolence; taste; thorax radiography
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Case report
/
Reviews
Language:
English
Journal:
Acta Medica Iranica
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS